Overview
No overview information available.
Indication
用于已经服用氯吡格雷和阿司匹林的急性冠状动脉综合征成年患者的动脉粥样硬化血栓形成的患者。预防非ST段抬高的急性冠脉综合征（不稳定型心绞痛/非Q波MI）患者的动脉粥样硬化血栓形成事件；有资格进行溶栓治疗的药物治疗患者的ST段抬高急性心肌梗死。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2012/08/03 | Phase 1 | Completed | |||
2011/08/23 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Clopidogrel Bisulfate and Aspirin Tablets | 国药准字H20223843 | 化学药品 | 片剂 | 11/15/2022 | |
| Clopidogrel Bisulfate and Aspirin Tablets | 国药准字HJ20210074 | 化学药品 | 片剂 | 9/30/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.